Email updates

Keep up to date with the latest news and content from Genome Biology and BioMed Central.

Research news

MODY-fying gene expression in diabetes

Jonathan B Weitzman

Genome Biology 2000, 1:spotlight-20000912-01  doi:10.1186/gb-spotlight-20000912-01

The electronic version of this article is the complete one and can be found online at:


Published:12 September 2000

© 2000 BioMed Central Ltd

Research news

HNF1α (hepatocyte nuclear factor 1) was originally isolated as a liver transcription factor. So it came as a sweet surprise to researchers when HNF1α was identified as the gene mutated in patients suffering from MODY3, maturity onset diabetes of the young subtype 3. As they report in the 15 August EMBO Journal Wang et al. (EMBO Journal 2000, 19:4257-4264) used a tetracyclin-regulated system to identify genes controlled by HNF1α. They expressed the most common diabetes-associated mutant form of HNF1α (P291fsinsC) in the INS-1 insulinoma cell line. This mutant form reduced the expression of several genes important for pancreatic β-cell function and inhibited expression of the insulin gene. Other genes suppressed by HNF1α include those involved in glucose transport (GLUT2) and glycolysis (e.g. encoding proteins aldolase B and L-pyruvate kinase). These inhibitory effects result in reduced cellular insulin, insulin secretion and ATP production.

References

  1. Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young.

    PubMed Abstract OpenURL

  2. [http://www.emboj.org/] webcite

    EMBO Journal

  3. Transcriptional activation by tetracyclines in mammalian cells.

    PubMed Abstract OpenURL